Walleye Capital’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.28M	Buy	288,532 +15,800	+6%	+$306K	0.04%	656
2025 Q4	$5.87M	Buy	272,732 +115,952	+74%	+$2.44M	0.03%	1021
2025 Q3	$3.02M	Sell	156,780 -279,445	-64%	-$4.98M	0.02%	1280
2025 Q2	$7.46M	Buy	436,225 +423,278	+3,269%	+$18.1M	0.07%	645
2025 Q1	$826K	Buy	12,947 +8,515	+192%	+$896K	0.01%	2130
2024 Q4	$539K	Sell	4,432 -5,453	-55%	-$668K	0.01%	2917
2024 Q3	$1.23M	Sell	9,885 -25,777	-72%	-$3.56M	0.01%	2422
2024 Q2	$5.63M	Sell	35,662 -4,317	-11%	-$555K	0.06%	1202
2024 Q1	$5.18M	Sell	39,979 -68,862	-63%	-$8.44M	0.06%	1268
2023 Q4	$10.5M	Buy	108,841 +67,073	+161%	+$6.43M	0.15%	643
2023 Q3	$5.06M	Buy	41,768 +31,032	+289%	+$3.51M	0.07%	1033
2023 Q2	$1.23M	Sell	10,736 -9,593	-47%	-$1.24M	0.02%	1680
2023 Q1	$2.8M	Sell	20,329 -27,340	-57%	-$3.55M	0.06%	538
2022 Q4	$6.18M	Buy	+47,669	New	+$5.52M	0.13%	225
2022 Q3	–	Hold	0	–	–	–	3678
2022 Q2	–	Sell	-53,361	Closed	-$4.17M	–	2727
2022 Q1	$4.17M	Buy	53,361 +31,488	+144%	+$2.41M	0.12%	192
2021 Q4	$1.97M	Buy	21,873 +17,626	+415%	+$1.51M	0.07%	328
2021 Q3	$393	Buy	+4,247	New	+$327K	0.01%	895
2021 Q2	–	Sell	-11,282	Closed	-$841	–	1511
2021 Q1	$841	Buy	+11,282	New	+$1.04M	0.05%	368
2020 Q1	–	Hold	0	–	–	–	1781
2019 Q4	–	Hold	0	–	–	–	2513
2019 Q3	–	Sell	-11,111	Closed	-$1.31M	–	2589
2019 Q2	$1.69M	Buy	+11,111	New	+$1.35M	1.65%	134